UH Urologist Designated as a Center for Excellence for GreenLight™ Laser Therapy for Enlarged Prostate Treatment
April 06, 2021
CLEVELAND, Ohio—University Hospitals' (UH) Irina Jaeger, MD, received the prestigious designation as a Center of Excellence for GreenLight™ Laser Therapy treatment – a minimally invasive outpatient procedure for men looking to treat their benign prostatic hyperplasia (BPH), not just the symptoms. Dr. Jaeger is a urologist at UH Richmond Medical Center and UH Brainard Medical Building in Lyndhurst.
GreenLight Therapy can help provide immediate relief from enlarged prostate symptoms such as frequent urination—especially at night, weak urine flow, urgency and incomplete bladder emptying. In addition, GreenLight Laser Therapy requires no incisions and typically has no overall deleterious impact on sexual function.
The Center of Excellence designation recognizes Dr. Jaeger’s high degree of experience with GreenLight Laser Therapy and commitment to delivering effective, long-lasting therapy to men suffering from BPH.
“We are honored to have Dr. Jaeger on our team as the first physician in Ohio and first woman in the country to be designated as a GreenLight Center of Excellence,” said Lee E. Ponsky, MD, Chair, UH Urology Institute. “When it comes to patient care, she sets a new standard. This is a meaningful recognition for us at UH, as we strive to provide the best possible treatment of urological conditions for patients in Northeast Ohio.”
BPH is a condition in which a man’s prostate enlarges and squeezes the urethra, causing frustrating symptoms such as frequent or urgent urination, a weak or interrupted urine stream, and the need to get up several times a night to urinate. It affects about 50 percent of men by age 60, and up to 90 percent of men by age 85.
GreenLight™ Laser Therapy uses laser energy to vaporize the enlarged tissue, creating an open channel for urine to pass through the urethra. In addition to typically experiencing immediate improvements in urine flow, many patients are pleased to know that GreenLight typically has no overall deleterious impact on sexual function. GreenLight™ Laser therapy is a long-term solution without the need for BPH medication.
“For years, the primary options for treating BPH were through behavior modifications, medications or invasive surgery,” emphasized Dr. Jaeger. “However, medications may not work for all patients and can potentially have undesirable side effects such as dizziness, sexual dysfunction and lower sex drive. With GreenLight Therapy, I’m able to provide relief of BPH for men who do not want to take medication or want to avoid invasive surgery and implants.”
GreenLight Therapy is currently being used in many leading urology practices throughout the United States. To date, more than one million patients around the world have been successfully treated with GreenLight Therapy.
Dr. Jaeger is also the only woman physician in Ohio designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Jaeger has achieved a high level of training and experience with the UroLift System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with BPH.
UroLift System is a novel, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating or removing prostate tissue.
For more information about BPH, visit https://www.uhhospitals.org/TreatMyBPH.
Interested patients can also schedule a consultation with Dr. Jaeger by calling (216) 545-7046.
Tags: Awards, Surgery, Urology, UH community hospitals